Axel Stover, Ph.D. has extensive Biotechnology development experience in startup acquisition as well as large corporate settings, most recently at Fresenius Kabi prior to joining Abbott. He has a total of 14 Invention Records and 2 patents to his name, and he has published on a variety of subtopics in the molecular microarray peer-reviewed space. Axel achieved a Ph.D. with distinction from Loyola University (Chicago) in Microbiology and Immunology.